Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii (Q43705318)

26 November 2017

Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii (English)

1 reference

26 November 2017

Acinetobacter baumannii

1 reference

Evangelos J Giamarellos-Bourboulis

inferred from title

multiple drug resistance

1 reference

1 reference

series ordinal

1

1 reference

26 November 2017

3

1 reference

26 November 2017

Xirouchaki E

2

1 reference

26 November 2017

1 July 2001

1 reference

Diagnostic Microbiology and Infectious Disease

26 November 2017

1 reference

26 November 2017

40

1 reference

26 November 2017

117-120

1 reference

26 November 2017

3

1 reference

A reassessment of the in-vitro activity of colistin sulphomethate sodium.

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900258-9

7 January 2021

Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900258-9

7 January 2021

Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900258-9

7 January 2021

Emergence of resistant isolates of Acinetobacter calcoaceticus- A. baumannii complex in a Spanish hospital over a five-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900258-9

7 January 2021

In-vitro activity of FK 037 (Cefoselis), a novel 4(th) generation cephalosporin, compared to cefepime and cefpirome on nosocomial staphylococci and gram-negative isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900258-9

7 January 2021

Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900258-9

7 January 2021

In-vitro activity of the combination of colistin and rifampicin against multidrug-resistant strains of Acinetobacter baumannii.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900258-9

7 January 2021

Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900258-9

7 January 2021

The comparative inhibitory and bactericidal activities of meropenem and imipenem against Acinetobacter spp. and Enterobacteriaceae resistant to second generation cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900258-9

7 January 2021

Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900258-9

7 January 2021

In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900258-9

7 January 2021

10.1016/S0732-8893(01)00258-9

Identifiers

DOI

1 reference

26 November 2017

1 reference

PubMed ID

11502379